CD5 and non-Hodgkin lymphoma: Based upon these attributes, besides the relevant immunohistochemistry showing focal positivity for CD3 and CD5, an initial diagnosis of Non-Hodgkin’s Lymphoma (NHL) favoring T cell lymphoblastic leukemia was entertained (Figure 4A).